Weekend batch
Your City | | | 12 Oct -27 Oct 2024, Weekend batch | Your City | |
| 26 Oct -10 Nov 2024, Weekend batch | Your City | |
About the Author
![what is p value in statistics hypothesis testing Avijeet Biswal](https://www.simplilearn.com/ice9/team_images/author_avijeet.jpg)
Avijeet is a Senior Research Analyst at Simplilearn. Passionate about Data Analytics, Machine Learning, and Deep Learning, Avijeet is also interested in politics, cricket, and football.
Recommended Resources
![what is p value in statistics hypothesis testing The Key Differences Between Z-Test Vs. T-Test](https://i.ytimg.com/vi/tUsHyIrNVNw/hqdefault.jpg)
Free eBook: Top Programming Languages For A Data Scientist
![what is p value in statistics hypothesis testing Normality Test in Minitab: Minitab with Statistics](https://www.simplilearn.com/ice9/free_resources_article_thumb/normality-test-in-minitab-article.jpg)
Normality Test in Minitab: Minitab with Statistics
![what is p value in statistics hypothesis testing A Comprehensive Look at Percentile in Statistics](https://i.ytimg.com/vi/NpmPYVGqMg4/hqdefault.jpg)
Machine Learning Career Guide: A Playbook to Becoming a Machine Learning Engineer
- PMP, PMI, PMBOK, CAPM, PgMP, PfMP, ACP, PBA, RMP, SP, and OPM3 are registered marks of the Project Management Institute, Inc.
Pardon Our Interruption
As you were browsing something about your browser made us think you were a bot. There are a few reasons this might happen:
- You've disabled JavaScript in your web browser.
- You're a power user moving through this website with super-human speed.
- You've disabled cookies in your web browser.
- A third-party browser plugin, such as Ghostery or NoScript, is preventing JavaScript from running. Additional information is available in this support article .
To regain access, please make sure that cookies and JavaScript are enabled before reloading the page.
![what is p value in statistics hypothesis testing caltech](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2023/02/caltech_updated_logo.png)
Caltech Bootcamp / Blog / /
What is Bayesian Statistics, and How Does it Differ from Classical Methods?
- Written by John Terra
- Updated on August 14, 2024
![what is p value in statistics hypothesis testing what is bayesian statistics](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/08/what-is-bayesian-statistics.jpg)
We humans are creatures of belief. Our beliefs guide us, shape our perceptions, and dictate many actions. However, people who value personal growth and learning will modify their beliefs by acquiring new information. Fields like artificial intelligence and machine learning embrace this kind of growth, and that’s what we’re here for today.
This article explores Bayesian statistics, including its definition, fundamentals, usage, pros and cons, and how a data science bootcamp can help you learn how to use statistical tools (and others) to bolster your career skill set.
So, what are Bayesian statistics?
What is Bayesian Statistics?
Put simply, Bayesian statistics is a data analysis approach based on Bayes’ theorem. According to this theorem, available knowledge regarding parameters in statistical models is updated using the information gathered from observed data. So, Bayesian statistics gives us the mathematical tools to update our beliefs regarding random events by incorporating new evidence or data about said events.
The Bayes theorem is a mathematical formula that determines the conditional probability of any given event. Conditional probability is defined as the chance a given event will happen based on previous knowledge of the occurrences of prior outcomes.
Bayesian statistics is used today in statistical analysis to make data-based decisions, deal with uncertainty and probability, and draw inferences from analyses.
Also Read: Technology at Work: Data Science in Finance
Digging into Bayesian Statistical Fundamentals
Let’s break down Bayesian statistics into its fundamental components.
- Conditional probability is the probability of an event (A), given (B), which is essential for updating beliefs. For instance, a medical researcher may want to explore the conditional probability of someone developing cancer, given a specific risk factor, like smoking. We can carry this into Bayesian statistics and update our beliefs using Bayes’ rule, working alongside the three essential elements in any given Bayesian analysis: prior distribution, likelihood, and posterior distribution.
- Prior distribution is a reasonable belief about the plausibility of an unknown parameter’s values of interest without any evidence from the new data we are analyzing.
- Likelihood covers the different possible values of the parameter based on new data analysis.
- Posterior distribution combines prior distribution and the likelihood using Bayes’ rule:
P(A|B) = [P(B|A). P(A)]/P(B)
In this rule, P(A) and P(B) represent the probabilities of the events A and B.
P(A|B) represents the probability of event A happening, given B.
P(B|A) represents the probability of event B happening, given A.
This process of updating prior beliefs using Bayes’ rule is known as Bayesian updating. The information we are trying to update can be called the prior. Note that the prior can take other data forms. For example, a prior could be a statistical estimate from a previous analysis or an estimate based on domain knowledge or belief. A prior belief doesn’t have to be quantifiable as a probability and, in some cases, could be subjective or qualitative. For instance, the prior belief could be our researcher mentioned above’s opinion on whether a patient had a specific form of cancer before any diagnostic tests could be conducted. The resulting information is the posterior after using the Bayes’ rule to update the prior. Thus, posterior distributions form the basis of statistical inferences made with a Bayesian analysis.
So, how does Bayesian statistics differ from frequentist statistics? And what is a frequentist statistic, anyway?
Bayesian vs. Frequentist Statistics
Frequentist statistics, also called classical statistics, assumes that probabilities are the frequency of particular random events happening in a long series of repeated trials. The primary difference between these two methodologies hinges on how they deal with uncertainty. For example, a Frequentist relies on long-term frequencies and assumes that probabilities are fixed and objective. On the other hand, Bayesians embrace subjectivity and the belief that probabilities change depending on additional new information.
Let’s look at the example of rolling a fair, balanced, six-sided die. If you roll that die 500 times, you may encounter a situation where you roll four sixes in a row. However, throughout those 500 rolls, you will get a six result once out of every six times. Thus, a Frequentist would conclude that a die roller has a one in six probability of obtaining a six result on their next roll.
Bayesians see it differently. For example, consider the probability of rolling greater than a four on that six-sided die. Two numbers (five and six) are greater than four and six possibilities. So, you divide two by six and get 0.33333, and that’s your probability of rolling greater than a four on the die.
Also Read: Five Outstanding Data Visualization Examples for Marketing
Should You Use Bayesian or Frequentist Statistics in A/B Testing?
A/B testing, alternately referred to as split testing, compares two or more different versions of something to determine which works better. A/B testing in a digital format, like for a website or a marketing e-mail campaign, tries to identify which version performs better in creating a desired outcome, such as clicks, signups, or engagement.
In the frequentist approach to A/B testing, tests begin by assuming that there is no difference between the two variations. The goal is to determine whether the results are meaningful enough to disprove that initial assumption.
However, with the Bayesian statistical methodology, prior knowledge forms the initial hypothesis, and the beliefs are adjusted and updated as new data surfaces. Unlike the frequentist approach, which establishes strict boundaries on whether something’s 100% true or false, the Bayesian approach gives probabilities of whether the hypothesis is true or false. For example, there could be a 75 percent chance the hypothesis is true and a 25 percent chance it’s false.
So, the best methodology for conducting your next A/B test should depend on the sample size, context, and whether or not you’re incorporating beliefs or prior knowledge into your process.
How to Use Bayesian Methodology When Conducting an A/B Test
You don’t have to be a data scientist to effectively use Bayesian methodology in running an A/B test. Follow these simple steps:
Form your hypothesis
Suppose you hypothesize that a more accessible sign-up form will encourage more people to sign up for free product trials. You believe reducing the form’s required fields will make things easier, minimize friction, and streamline the process, resulting in greater participation.
Determine the probability that the hypothesis is true
You’ve had good results using shorter lead capture forms for similar campaigns, such as product demo requests. Based on that experience and information, you guess there’s a 70 percent chance of success if you condensed the new user sign-up form.
Collect the data and calculate posterior probabilities
Collect the data on sign-up rates as users interact with your new form. Update the hypothesis and assumptions as the new data rolls in. This updated value becomes your posterior probability.
Iterate, collect more data, repeat
Now, that new posterior probability becomes the prior probability for the next round of testing. For this example, sign-up rates increased by 25 percent with the new form, so this information becomes the new prior probability. Repeat the cycle, refining and optimizing as needed.
Also Read: Data Science Bootcamps vs. Traditional Degrees: Which Learning Path to Choose?
The Advantages vs. Disadvantages of Bayesian Statistics
Let’s briefly explore the pros and cons of Bayesian statistics.
Advantages of Bayesian Statistics
- It handles multiple tests well. Since testing isn’t forced into a true/false proposition, Bayesian statistics is well-suited for multiple testing situations.
- It offers incorporation of previous information and continuous updating. Bayesian statistics shines in situations where there’s a lot of prior data. This information boosts the statistical power to find relevant associations and make studies more efficient. The current posterior can be used as the prior knowledge element in future studies.
- It’s an intuitive interpretation. The Bayesian process is remarkably similar to how humans process information in their minds, making it more intuitive to use.
- It generalizes classical analysis. Classical statistical inference assumes no prior knowledge. Bayesian statistics helps narrow down what could be an infinite number (due to no prior information) based on prior knowledge.
Disadvantages of Bayesian Statistics
- Defining prior distributions can be challenging. Implementing prior information isn’t straightforward, and experts may find it difficult to translate the knowledge into statistical terms.
- It poses greater technical complexity. Many calculations that power Bayesian analysis require integral computations and operations with distributions. Skills in Bayesian programming are also helpful.
- It can be computationally intense. Computing complex integrals and using iterative methods for estimation can slow down the process and unduly absorb a significant amount of computer processing.
- There’s a strong potential for subjectivity. Although Bayesian statistics is typically more intuitive and results are easier to interpret, probabilistic outputs are arguably more subjective, leading to different interpretations and decision-making choices. Everyone assesses risks and probabilities differently so that other actions might be taken based on the same result.
Also Read: Data Scientist vs. Machine Learning Engineer
How to Increase Your Data Science Proficiency
Bayesian statistics is part of data science, an exciting field that figures prominently in many of today’s hot technologies, such as artificial intelligence and machine learning. If you want to learn more about data science and how to turn it into a career asset, consider an online data science program . This 44-week bootcamp covers descriptive and inferential statistics, exploratory data analysis, model building and fine-tuning, large language models (LLM), generative AI, and more.
Glassdoor.com reports that data scientists earn an average salary of $112,874. Check out this course if you want to immerse yourself in the world of data science and make it a career path.
You might also like to read:
What is Natural Language Generation in Data Science, and Why Does It Matter?
What is Data Wrangling? Importance, Tools, and More
What is Spatial Data Science? Definition, Applications, Careers & More
Data Science and Marketing: Transforming Strategies and Enhancing Engagement
An Introduction to Natural Language Processing in Data Science
Data Science Bootcamp
Online Bootcamp
Leave a comment cancel reply.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Recommended Articles
![what is p value in statistics hypothesis testing what is data imputation](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/08/what-is-data-imputation-300x163.jpg)
What is Data Imputation, and How Can You Use it to Handle Missing Data?
This article defines data imputation and demonstrates its importance, techniques, and challenges.
![what is p value in statistics hypothesis testing What is Data Governance](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/08/what-is-data-governance-300x163.jpg)
What is Data Governance, How Does it Work, Who Performs it, and Why is it Essential?
What is data governance? This article explores its goals and components, how to implement it, best practices, and more.
![what is p value in statistics hypothesis testing What is Data Visualization](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/07/What-is-Data-Visualization-300x163.jpg)
What is Data Visualization, and What is its Role in Data Science?
Visualizing data can transform complex information into meaningful insights. This guide answers the question: “What is data visualization?” and discusses everything you need to know about it.
![what is p value in statistics hypothesis testing Data Science in Finance](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/07/Data-Science-in-Finance-300x163.jpg)
Technology at Work: Data Science in Finance
In today’s data-driven world, industries leverage advanced data analytics and AI-powered tools to improve services and their bottom line. The financial services industry is at the forefront of this innovation. This blog discusses data science in finance, including how companies use it, the skills required to leverage it, and more.
![what is p value in statistics hypothesis testing Data Science Interview Questions](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2023/08/Data-Science-Interview-Questions-300x169.jpg)
The Top Data Science Interview Questions for 2024
This article covers popular basic and advanced data science interview questions and the difference between data analytics and data science.
![what is p value in statistics hypothesis testing Big Data and Analytics](https://pg-p.ctme.caltech.edu/wp-content/uploads/sites/4/2024/06/Big-Data-and-Analytics-300x169.jpg)
Big Data and Analytics: Unlocking the Future
Unlock the potential and benefits of big data and analytics in your career. Explore essential roles and discover the advantages of data-driven decision-making.
Learning Format
Program Benefits
- 12+ tools covered, 25+ hands-on projects
- Masterclasses by distinguished Caltech CTME instructors
- Caltech CTME Circle Membership
- Industry-specific training from global experts
- Call us on : 1800-212-7688
Information
Initiatives
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
- Active Journals
- Find a Journal
- Proceedings Series
- For Authors
- For Reviewers
- For Editors
- For Librarians
- For Publishers
- For Societies
- For Conference Organizers
- Open Access Policy
- Institutional Open Access Program
- Special Issues Guidelines
- Editorial Process
- Research and Publication Ethics
- Article Processing Charges
- Testimonials
- Preprints.org
- SciProfiles
- Encyclopedia
![Diagnostics diagnostics-logo](https://pub.mdpi-res.com/img/journals/diagnostics-logo.png?8600e93ff98dbf14)
Article Menu
![what is p value in statistics hypothesis testing what is p value in statistics hypothesis testing](https://www.mdpi.com/bundles/mdpisciprofileslink/img/unknown-user.png)
- Subscribe SciFeed
- Recommended Articles
- Google Scholar
- on Google Scholar
- Table of Contents
Find support for a specific problem in the support section of our website.
Please let us know what you think of our products and services.
Visit our dedicated information section to learn more about MDPI.
JSmol Viewer
Cardiovascular disease risk stratification using hybrid deep learning paradigm: first of its kind on canadian trial data.
![ORCID what is p value in statistics hypothesis testing](https://pub.mdpi-res.com/img/design/orcid.png?0465bc3812adeb52?1724941758)
1. Introduction
2. the background literature, 3. methodology, 3.1. patient demographics and baseline characteristics, 3.2. acquisition of ultrasound scans and intraplaque neovascularization, 3.3. cardiovascular disease endpoint: angiographic score, 3.4. overall architecture, 3.4.1. data preparation and pre-processing, 3.4.2. model building, 3.4.3. the rationale behind using rnn, gru, and lstm, 3.5. experimental protocols, 3.5.1. experimental protocol 1: three unidirectional models, 3.5.2. experimental protocol 2: three bidirectional models, 3.5.3. experimental protocol 3: six hybrid models, 3.6. loss function and training parameters, 3.7. performance metrics, 4.1. accuracy and loss curves, 4.2. results of experimental protocol 1, 4.3. results of experimental protocol 2, 4.4. results of experimental protocol 3, 4.5. comparison of three feature selection methods for three machine learning models, 5. performance evaluation, 5.1. receiver operating characteristics of all four kinds of ai models, 5.2. effect of sample sizes on the training system, 5.3. hybrid deep learning performance against other ai models, 6. scientific validation, 7. reliability and stability of hybrid deep learning system, 8. discussion, 8.1. benchmarking table, 8.2. a special note on hybrid deep learning, 8.3. strengths, weaknesses, and extensions, 9. conclusions, author contributions, institutional review board statement, informed consent statement, data availability statement, acknowledgments, conflicts of interest, appendix a. unidirectional architecture.
SN | Risk Factors or Target Variable | Samples (N) or Mean | Pr (%) |
---|
1 | Age | 64.49 years | - |
2 | Gender | 349 | 69.8 |
3 | Obesity | 215 | 43.0 |
4 | Ethnicity | 486 | 97.2 |
5 | BMI | 31.12 kg/m | - |
6 | Hypertension | 338 | 67.6 |
7 | Angina | 124 | 24.8 |
8 | Diastolic blood pressure | 76.7 mmHg | - |
9 | Systolic blood pressure | 135.35 mmHg | - |
10 | Smoking history | 330 | 66.0 |
11 | Casual smoker | 15 | 3.0 |
12 | Current smoker | 100 | 20.0 |
13 | Previous smoker | 218 | 43.6 |
14 | Drinks | 4.94 ± 10.4 per week | - |
15 | Family history of diabetics | 195 | 39.0 |
16 | Premature CVD in the family | 146 | 29.2 |
17 | CVD in the family | 321 | 64.2 |
18 | Pre-diabetic | 20 | 40.0 |
19 | Hyperlipidemia | 288 | 57.6 |
20 | Type II diabetes | 114 | 22.8 |
21 | Type I diabetes | 5 | 1.0 |
22 | Creatinine | 83.99 ± 22.6 μmol/L | - |
23 | Estimated glomerular filtration rate | 78.96 mL/min/1.73 m | - |
24 | Diabetes of any type | 118 | 23.6 |
25 | Total plaque area (TPA) | 47.68 mm | - |
26 | Maximum plaque height (MPH) | 2.64 mm | - |
27 | Intra-plaque neovascularization (IPN) | 1.16 | - |
28 | Angiotensin-converting enzyme (ACE) inhibitors | 191 | 38.2 |
29 | HMG-Co reductase inhibitors | 272 | 54.4 |
30 | Angiotensin receptor blockers (ARBs) | 45 | 9.0 |
31 | Other antilipemic agents | 9 | 1.80 |
32 | Alpha-blockers | 30 | 6.0 |
33 | Calcium channel-blockers | 93 | 18.6 |
34 | Beta-blockers | 236 | 47.2 |
35 | Diuretics | 99 | 19.8 |
36 | Anti-platelet | 368 | 73.6 |
37 | Insulin | 38 | 7.6 |
38 | Anti-anginals and NSAIDS | 81 | 16.20 |
39 | Non-insulin diabetes medications | 72 | 14.4 |
Appendix B. Unidirectional Architecture
Click here to enlarge figure
Appendix C. Bidirectional Architecture
Appendix d. hybrid deep learning architecture, appendix e. scientific validation with the unseen data.
Unseen Data (Train A-Test B) | Unseen Data (Train B-Test A) |
---|
SN | Models | Mean AUC | p-Value | Mean AUC | p-Value |
---|
1 | ML | 0.683 | <0.005 | 0.683 | <0.005 |
2 | UniDL | 0.884 | <0.001 | 0.880 | <0.001 |
3 | BiDL | 0.905 | <0.001 | 0.900 | <0.001 |
4 | HDL | 0.947 | <0.001 | 0.940 | <0.001 |
Appendix F. Confusion Matrix for Unidirectional HDL and Bidirectional HDL Model
- Kaptoge, S.; Pennells, L.; De Bacquer, D.; Cooney, M.T.; Kavousi, M.; Stevens, G.; Riley, L.M.; Savin, S.; Khan, T.; Altay, S.; et al. World Health Organization cardiovascular disease risk charts: Revised models to estimate risk in 21 global regions. Lancet Glob. Health 2019 , 7 , e1332–e1345. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Suri, J.S.; Agarwal, S.; Gupta, S.K.; Puvvula, A.; Biswas, M.; Saba, L.; Bit, A.; Tandel, G.S.; Agarwal, M.; Patrick, A.; et al. A narrative review on characterization of acute respiratory distress syndrome in COVID-19-infected lungs using artificial intelligence. Comput. Biol. Med. 2021 , 130 , 104210. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Jamthikar, A.D.; Puvvula, A.; Gupta, D.; Johri, A.M.; Nambi, V.; Khanna, N.N.; Saba, L.; Mavrogeni, S.; Laird, J.R.; Pareek, G. Cardiovascular disease and stroke risk assessment in patients with chronic kidney disease using integration of estimated glomerular filtration rate, ultrasonic image phenotypes, and artificial intelligence: A narrative review. Int. Angiol. A J. Int. Union Angiol. 2020 , 40 , 150–164. [ Google Scholar ] [ CrossRef ]
- Saba, L.; Anzidei, M.; Sanfilippo, R.; Montisci, R.; Lucatelli, P.; Catalano, C.; Passariello, R.; Mallarini, G. Imaging of the carotid artery. Atherosclerosis 2012 , 220 , 294–309. [ Google Scholar ] [ CrossRef ]
- Griffin, M.; Nicolaides, A.N.; Belcaro, G.; Shah, E. Cardiovascular risk assessment using ultrasound: The value of arterial wall changes including the presence, severity and character of plaques. Pathophysiol. Haemost. Thromb. 2002 , 32 , 367–370. [ Google Scholar ] [ CrossRef ]
- Suri, J.S.; Kathuria, C.; Molinari, F. Atherosclerosis Disease Management ; Springer: Berlin/Heidelberg, Germany, 2010. [ Google Scholar ]
- Saba, L.; Jamthikar, A.; Gupta, D.; Khanna, N.N.; Viskovic, K.; Suri, H.S.; Gupta, A.; Mavrogeni, S.; Turk, M.; Laird, J.R. Global perspective on carotid intima-media thickness and plaque: Should the current measurement guidelines be revisited? Int. Angiol. 2019 , 38 , 451–465. [ Google Scholar ] [ CrossRef ]
- Giannopoulos, A.A.; Kyriacou, E.; Griffin, M.; Pattichis, C.S.; Michael, J.; Richards, T.; Geroulakos, G.; Nicolaides, A.N. Dynamic carotid plaque imaging using ultrasonography. J. Vasc. Surg. 2021 , 73 , 1630–1638. [ Google Scholar ] [ CrossRef ]
- Amato, M.; Montorsi, P.; Ravani, A.; Oldani, E.; Galli, S.; Ravagnani, P.M.; Tremoli, E.; Baldassarre, D. Carotid intima-media thickness by B-mode ultrasound as surrogate of coronary atherosclerosis: Correlation with quantitative coronary angiography and coronary intravascular ultrasound findings. Eur. Heart J. 2007 , 28 , 2094–2101. [ Google Scholar ] [ CrossRef ]
- Bots, M.L. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr. Med. Res. Opin. 2006 , 22 , 2181–2190. [ Google Scholar ] [ CrossRef ]
- Spence, J.D. Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease. Am. J. Cardiol. 2002 , 89 , 10–15. [ Google Scholar ] [ CrossRef ]
- Puvvula, A.; Jamthikar, A.D.; Gupta, D.; Khanna, N.N.; Porcu, M.; Saba, L.; Viskovic, K.; Ajuluchukwu, J.N.; Gupta, A.; Mavrogeni, S. Morphological carotid plaque area is associated with glomerular filtration rate: A study of south asian indian patients with diabetes and chronic kidney disease. Angiology 2020 , 71 , 520–535. [ Google Scholar ] [ CrossRef ]
- Biswas, M.; Saba, L.; Chakrabartty, S.; Khanna, N.N.; Song, H.; Suri, H.S.; Sfikakis, P.P.; Mavrogeni, S.; Viskovic, K.; Laird, J.R. Two-stage artificial intelligence model for jointly measurement of atherosclerotic wall thickness and plaque burden in carotid ultrasound: A screening tool for cardiovascular/stroke risk assessment. Comput. Biol. Med. 2020 , 123 , 103847. [ Google Scholar ] [ CrossRef ]
- Landry, A.; Spence, J.D.; Fenster, A. Measurement of carotid plaque volume by 3-dimensional ultrasound. Stroke 2004 , 35 , 864–869. [ Google Scholar ] [ CrossRef ]
- Johri, A.M.; Lajkosz, K.A.; Grubic, N.; Islam, S.; Li, T.Y.; Simpson, C.S.; Ewart, P.; Suri, J.S.; Hétu, M.-F. Maximum plaque height in carotid ultrasound predicts cardiovascular disease outcomes: A population-based validation study of the American society of echocardiography’s grade II–III plaque characterization and protocol. Int. J. Cardiovasc. Imaging 2021 , 37 , 1601–1610. [ Google Scholar ] [ CrossRef ]
- Mantella, L.E.; Colledanchise, K.N.; Hetu, M.-F.; Feinstein, S.B.; Abunassar, J.; Johri, A.M. Carotid intraplaque neovascularization predicts coronary artery disease and cardiovascular events. Eur. Heart J. Cardiovasc. Imaging 2019 , 20 , 1239–1247. [ Google Scholar ] [ CrossRef ]
- Goldstein, B.A.; Navar, A.M.; Carter, R.E. Moving beyond regression techniques in cardiovascular risk prediction: Applying machine learning to address analytic challenges. Eur. Heart J. 2017 , 38 , 1805–1814. [ Google Scholar ] [ CrossRef ]
- Jamthikar, A.D.; Gupta, D.; Saba, L.; Khanna, N.N.; Viskovic, K.; Mavrogeni, S.; Laird, J.R.; Sattar, N.; Johri, A.M.; Pareek, G. Artificial intelligence framework for predictive cardiovascular and stroke risk assessment models: A narrative review of integrated approaches using carotid ultrasound. Comput. Biol. Med. 2020 , 126 , 104043. [ Google Scholar ] [ CrossRef ]
- Alaa, A.M.; Bolton, T.; Di Angelantonio, E.; Rudd, J.H.; Van der Schaar, M. Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants. PLoS ONE 2019 , 14 , e0213653. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Weng, S.F.; Reps, J.; Kai, J.; Garibaldi, J.M.; Qureshi, N. Can machine-learning improve cardiovascular risk prediction using routine clinical data? PLoS ONE 2017 , 12 , e0174944. [ Google Scholar ] [ CrossRef ]
- Biswas, M.; Kuppili, V.; Saba, L.; Edla, D.R.; Suri, H.S.; Cuadrado-Godia, E.; Laird, J.R.; Marinhoe, R.T.; Sanches, J.M.; Nicolaides, A. State-of-the-art review on deep learning in medical imaging. Front. Biosci. Landmark 2019 , 24 , 380–406. [ Google Scholar ]
- Saba, L.; Biswas, M.; Kuppili, V.; Godia, E.C.; Suri, H.S.; Edla, D.R.; Omerzu, T.; Laird, J.R.; Khanna, N.N.; Mavrogeni, S. The present and future of deep learning in radiology. Eur. J. Radiol. 2019 , 114 , 14–24. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Hosny, A.; Parmar, C.; Quackenbush, J.; Schwartz, L.H.; Aerts, H.J. Artificial intelligence in radiology. Nat. Rev. Cancer 2018 , 18 , 500–510. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Pianykh, O.S.; Langs, G.; Dewey, M.; Enzmann, D.R.; Herold, C.J.; Schoenberg, S.O.; Brink, J.A. Continuous learning AI in radiology: Implementation principles and early applications. Radiology 2020 , 297 , 6–14. [ Google Scholar ] [ CrossRef ]
- Thrall, J.H.; Li, X.; Li, Q.; Cruz, C.; Do, S.; Dreyer, K.; Brink, J. Artificial intelligence and machine learning in radiology: Opportunities, challenges, pitfalls, and criteria for success. J. Am. Coll. Radiol. 2018 , 15 , 504–508. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Shrivastava, V.K.; Londhe, N.D.; Sonawane, R.S.; Suri, J.S. Reliable and accurate psoriasis disease classification in dermatology images using comprehensive feature space in machine learning paradigm. Expert Syst. Appl. 2015 , 42 , 6184–6195. [ Google Scholar ] [ CrossRef ]
- Shrivastava, V.K.; Londhe, N.D.; Sonawane, R.S.; Suri, J.S. A novel and robust Bayesian approach for segmentation of psoriasis lesions and its risk stratification. Comput. Methods Programs Biomed. 2017 , 150 , 9–22. [ Google Scholar ] [ CrossRef ]
- Du-Harpur, X.; Watt, F.; Luscombe, N.; Lynch, M. What is AI? Applications of artificial intelligence to dermatology. Br. J. Dermatol. 2020 , 183 , 423–430. [ Google Scholar ] [ CrossRef ]
- Li, C.-X.; Shen, C.-B.; Xue, K.; Shen, X.; Jing, Y.; Wang, Z.-Y.; Xu, F.; Meng, R.-S.; Yu, J.-B.; Cui, Y. Artificial intelligence in dermatology: Past, present, and future. Chin. Med. J. 2019 , 132 , 2017–2020. [ Google Scholar ] [ CrossRef ]
- Fritzsche, K.; Can, A.; Shen, H.; Tsai, C.; Turner, J.; Tanenbuam, H.; Stewart, C.; Roysam, B.; Suri, J.; Laxminarayan, S. Automated model based segmentation, tracing and analysis of retinal vasculature from digital fundus images. In State-of-The-Art Angiography, Applications and Plaque Imaging Using MR, CT, Ultrasound and X-rays ; CRC Press: Boca Raton, FL, USA, 2003; Volume 29, pp. 225–298. [ Google Scholar ]
- Hogarty, D.T.; Mackey, D.A.; Hewitt, A.W. Current state and future prospects of artificial intelligence in ophthalmology: A review. Clin. Exp. Ophthalmol. 2019 , 47 , 128–139. [ Google Scholar ] [ CrossRef ]
- Tong, Y.; Yu, Y.; Xing, Y.; Chen, C.; Shen, Y. Applications of artificial intelligence in ophthalmology: General overview. J. Ophthalmol. 2018 , 2018 , 5278196. [ Google Scholar ]
- Ting, D.S.W.; Pasquale, L.R.; Peng, L.; Campbell, J.P.; Lee, A.Y.; Raman, R.; Tan, G.S.W.; Schmetterer, L.; Keane, P.A.; Wong, T.Y. Artificial intelligence and deep learning in ophthalmology. Br. J. Ophthalmol. 2019 , 103 , 167–175. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Schmidt-Erfurth, U.; Reiter, G.S.; Riedl, S.; Seeböck, P.; Vogl, W.-D.; Blodi, B.A.; Domalpally, A.; Fawzi, A.; Jia, Y.; Sarraf, D. AI-based monitoring of retinal fluid in disease activity and under therapy. Prog. Retin. Eye Res. 2022 , 86 , 100972. [ Google Scholar ] [ CrossRef ]
- Sorrentino, F.S.; Jurman, G.; De Nadai, K.; Campa, C.; Furlanello, C.; Parmeggiani, F. Application of artificial intelligence in targeting retinal diseases. Curr. Drug Targets 2020 , 21 , 1208–1215. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Saba, L.; Sanfilippo, R.; Sannia, S.; Anzidei, M.; Montisci, R.; Mallarini, G.; Suri, J.S. Association between carotid artery plaque volume, composition, and ulceration: A retrospective assessment with MDCT. Am. J. Roentgenol. 2012 , 199 , 151–156. [ Google Scholar ] [ CrossRef ]
- Acharya, U.R.; Sree, S.V.; Krishnan, M.M.R.; Krishnananda, N.; Ranjan, S.; Umesh, P.; Suri, J.S. Automated classification of patients with coronary artery disease using grayscale features from left ventricle echocardiographic images. Comput. Methods Programs Biomed. 2013 , 112 , 624–632. [ Google Scholar ] [ CrossRef ]
- Johnson, K.W.; Soto, J.T.; Glicksberg, B.S.; Shameer, K.; Miotto, R.; Ali, M.; Ashley, E.; Dudley, J.T. Artificial intelligence in cardiology. J. Am. Coll. Cardiol. 2018 , 71 , 2668–2679. [ Google Scholar ] [ CrossRef ]
- Lopez-Jimenez, F.; Attia, Z.; Arruda-Olson, A.M.; Carter, R.; Chareonthaitawee, P.; Jouni, H.; Kapa, S.; Lerman, A.; Luong, C.; Medina-Inojosa, J.R. Artificial intelligence in cardiology: Present and future. In Mayo Clinic Proceedings ; Elsevier: Amsterdam, The Netherlands, 2020. [ Google Scholar ]
- Molinari, F.; Mantovani, A.; Deandrea, M.; Limone, P.; Garberoglio, R.; Suri, J.S. Characterization of single thyroid nodules by contrast-enhanced 3-D ultrasound. Ultrasound Med. Biol. 2010 , 36 , 1616–1625. [ Google Scholar ] [ CrossRef ]
- Gubbi, S.; Hamet, P.; Tremblay, J.; Koch, C.A.; Hannah-Shmouni, F. Artificial intelligence and machine learning in endocrinology and metabolism: The dawn of a new era. Front. Endocrinol. 2019 , 10 , 185. [ Google Scholar ] [ CrossRef ]
- Giorgini, F.; Di Dalmazi, G.; Diciotti, S. Artificial intelligence in endocrinology: A comprehensive review. J. Endocrinol. Investig. 2024 , 47 , 1067–1082. [ Google Scholar ] [ CrossRef ]
- Thomasian, N.M.; Kamel, I.R.; Bai, H.X. Machine intelligence in non-invasive endocrine cancer diagnostics. Nat. Rev. Endocrinol. 2022 , 18 , 81–95. [ Google Scholar ] [ CrossRef ]
- Jamthikar, A.; Gupta, D.; Khanna, N.N.; Saba, L.; Araki, T.; Viskovic, K.; Suri, H.S.; Gupta, A.; Mavrogeni, S.; Turk, M. A low-cost machine learning-based cardiovascular/stroke risk assessment system: Integration of conventional factors with image phenotypes. Cardiovasc. Diagn. Ther. 2019 , 9 , 420. [ Google Scholar ] [ CrossRef ]
- Kakadiaris, I.A.; Vrigkas, M.; Yen, A.A.; Kuznetsova, T.; Budoff, M.; Naghavi, M. Machine learning outperforms ACC/AHA CVD risk calculator in MESA. J. Am. Heart Assoc. 2018 , 7 , e009476. [ Google Scholar ] [ CrossRef ]
- Arsenescu, T.; Chifor, R.; Marita, T.; Santoma, A.; Lebovici, A.; Duma, D.; Vacaras, V.; Badea, A.F. 3D ultrasound reconstructions of the carotid artery and thyroid gland using artificial-intelligence-based automatic segmentation—Qualitative and quantitative evaluation of the segmentation results via comparison with CT angiography. Sensors 2023 , 23 , 2806. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Acharya, U.R.; Mookiah, M.R.K.; Sree, S.V.; Yanti, R.; Martis, R.; Saba, L.; Molinari, F.; Guerriero, S.; Suri, J.S. Evolutionary algorithm-based classifier parameter tuning for automatic ovarian cancer tissue characterization and classification. Ultraschall Med. Eur. J. Ultrasound 2014 , 35 , 237–245. [ Google Scholar ]
- Araki, T.; Ikeda, N.; Shukla, D.; Jain, P.K.; Londhe, N.D.; Shrivastava, V.K.; Banchhor, S.K.; Saba, L.; Nicolaides, A.; Shafique, S. PCA-based polling strategy in machine learning framework for coronary artery disease risk assessment in intravascular ultrasound: A link between carotid and coronary grayscale plaque morphology. Comput. Methods Programs Biomed. 2016 , 128 , 137–158. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Anaya-Isaza, A.; Mera-Jiménez, L.; Zequera-Diaz, M. An overview of deep learning in medical imaging. Inform. Med. Unlocked 2021 , 26 , 100723. [ Google Scholar ] [ CrossRef ]
- Lee, J.-G.; Jun, S.; Cho, Y.-W.; Lee, H.; Kim, G.B.; Seo, J.B.; Kim, N. Deep learning in medical imaging: General overview. Korean J. Radiol. 2017 , 18 , 570–584. [ Google Scholar ] [ CrossRef ]
- Aggarwal, R.; Sounderajah, V.; Martin, G.; Ting, D.S.; Karthikesalingam, A.; King, D.; Ashrafian, H.; Darzi, A. Diagnostic accuracy of deep learning in medical imaging: A systematic review and meta-analysis. NPJ Digit. Med. 2021 , 4 , 65. [ Google Scholar ] [ CrossRef ]
- Khanna, N.N.; Maindarkar, M.A.; Viswanathan, V.; Puvvula, A.; Paul, S.; Bhagawati, M.; Ahluwalia, P.; Ruzsa, Z.; Sharma, A.; Kolluri, R. Cardiovascular/Stroke Risk Stratification in Diabetic Foot Infection Patients Using Deep Learning-Based Artificial Intelligence: An Investigative Study. J. Clin. Med. 2022 , 11 , 6844. [ Google Scholar ] [ CrossRef ]
- Suri, J.S.; Bhagawati, M.; Paul, S.; Protogerou, A.D.; Sfikakis, P.P.; Kitas, G.D.; Khanna, N.N.; Ruzsa, Z.; Sharma, A.M.; Saxena, S. A powerful paradigm for cardiovascular risk stratification using multiclass, multi-label, and ensemble-based machine learning paradigms: A narrative review. Diagnostics 2022 , 12 , 722. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Johri, A.M.; Singh, K.V.; Mantella, L.E.; Saba, L.; Sharma, A.; Laird, J.R.; Utkarsh, K.; Singh, I.M.; Gupta, S.; Kalra, M.S. Deep learning artificial intelligence framework for multiclass coronary artery disease prediction using combination of conventional risk factors, carotid ultrasound, and intraplaque neovascularization. Comput. Biol. Med. 2022 , 150 , 106018. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Konstantonis, G.; Singh, K.V.; Sfikakis, P.P.; Jamthikar, A.D.; Kitas, G.D.; Gupta, S.K.; Saba, L.; Verrou, K.; Khanna, N.N.; Ruzsa, Z. Cardiovascular disease detection using machine learning and carotid/femoral arterial imaging frameworks in rheumatoid arthritis patients. Rheumatol. Int. 2022 , 42 , 215–239. [ Google Scholar ] [ CrossRef ]
- Jamthikar, A.D.; Gupta, D.; Mantella, L.E.; Saba, L.; Laird, J.R.; Johri, A.M.; Suri, J.S. Multiclass machine learning vs. conventional calculators for stroke/CVD risk assessment using carotid plaque predictors with coronary angiography scores as gold standard: A 500 participants study. Int. J. Cardiovasc. Imaging 2021 , 37 , 1171–1187. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Johri, A.M.; Mantella, L.E.; Jamthikar, A.D.; Saba, L.; Laird, J.R.; Suri, J.S. Role of artificial intelligence in cardiovascular risk prediction and outcomes: Comparison of machine-learning and conventional statistical approaches for the analysis of carotid ultrasound features and intra-plaque neovascularization. Int. J. Cardiovasc. Imaging 2021 , 37 , 3145–3156. [ Google Scholar ] [ CrossRef ]
- Wilson, P.W.; D’Agostino, R.B.; Levy, D.; Belanger, A.M.; Silbershatz, H.; Kannel, W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998 , 97 , 1837–1847. [ Google Scholar ] [ CrossRef ]
- Conroy, R.M.; Pyörälä, K.; Fitzgerald, A.E.; Sans, S.; Menotti, A.; De Backer, G.; De Bacquer, D.; Ducimetiere, P.; Jousilahti, P.; Keil, U. Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur. Heart J. 2003 , 24 , 987–1003. [ Google Scholar ] [ CrossRef ]
- Golf, D.C., Jr.; Lloyd-Jones, D.M.; Bennett, G.; Coady, S.; D’agostino, R.B.; Gibbons, R.; Greenland, P.; Lackland, D.T.; Levy, D.; O’donnell, C.J. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 , 129 (Suppl. S2), S49–S73. [ Google Scholar ]
- Kumar, K.; Araki, T.; Rajan, J.; Saba, L.; Lavra, F.; Ikeda, N.; Sharma, A.M.; Shafique, S.; Nicolaides, A.; Laird, J.R. Accurate lumen diameter measurement in curved vessels in carotid ultrasound: An iterative scale-space and spatial transformation approach. Med. Biol. Eng. Comput. 2017 , 55 , 1415–1434. [ Google Scholar ] [ CrossRef ]
- Detrano, R.; Guerci, A.D.; Carr, J.J.; Bild, D.E.; Burke, G.; Folsom, A.R.; Liu, K.; Shea, S.; Szklo, M.; Bluemke, D.A. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N. Engl. J. Med. 2008 , 358 , 1336–1345. [ Google Scholar ] [ CrossRef ]
- Poplin, R.; Varadarajan, A.V.; Blumer, K.; Liu, Y.; McConnell, M.V.; Corrado, G.S.; Peng, L.; Webster, D.R. Prediction of cardiovascular risk factors from retinal fundus photographs via deep learning. Nat. Biomed. Eng. 2018 , 2 , 158–164. [ Google Scholar ] [ CrossRef ]
- Escaned, J.; Baptista, J.; Di Mario, C.; Haase, J.R.; Ozaki, Y.; Linker, D.T.; De Feyter, P.J.; Roelandt, J.R.; Serruys, P.W. Significance of automated stenosis detection during quantitative angiography: Insights gained from intracoronary ultrasound imaging. Circulation 1996 , 94 , 966–972. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Bourantas, C.V.; Kalatzis, F.G.; Papafaklis, M.I.; Fotiadis, D.I.; Tweddel, A.C.; Kourtis, I.C.; Katsouras, C.S.; Michalis, L.K. ANGIOCARE: An automated system for fast three-dimensional coronary reconstruction by integrating angiographic and intracoronary ultrasound data. Catheter. Cardiovasc. Interv. 2008 , 72 , 166–175. [ Google Scholar ] [ CrossRef ]
- Joseph, J.; Kiran, R.; Nabeel, P.; Shah, M.I.; Bhaskar, A.; Ganesh, C.; Seshadri, S.; Sivaprakasam, M. ARTSENS® Pen—Portable easy-to-use device for carotid stiffness measurement: Technology validation and clinical-utility assessment. Biomed. Phys. Eng. Express 2020 , 6 , 025013. [ Google Scholar ] [ CrossRef ]
- Daigle, R.J. Techniques in Noninvasive Vascular Diagnosis: An Encyclopedia of Vascular Testing ; Summer Publishing LLC: Littleton, CO, USA, 2008. [ Google Scholar ]
- Nicolaides, A.N.; Kakkos, S.K.; Griffin, M.; Sabetai, M.; Dhanjil, S.; Thomas, D.J.; Geroulakos, G.; Georgiou, N.; Francis, S.; Ioannidou, E. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: Results from the asymptomatic carotid stenosis and risk of stroke study. Vascular 2005 , 13 , 211–221. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Chawla, N.V.; Bowyer, K.W.; Hall, L.O.; Kegelmeyer, W.P. SMOTE: Synthetic minority over-sampling technique. J. Artif. Intell. Res. 2002 , 16 , 321–357. [ Google Scholar ] [ CrossRef ]
- Elreedy, D.; Atiya, A.F. A comprehensive analysis of synthetic minority oversampling technique (SMOTE) for handling class imbalance. Inf. Sci. 2019 , 505 , 32–64. [ Google Scholar ] [ CrossRef ]
- Santoso, B.; Wijayanto, H.; Notodiputro, K.A.; Sartono, B. Synthetic over sampling methods for handling class imbalanced problems: A review. In IOP Conference Series: Earth and Environmental Science ; IOP Publishing: Bristol, UK, 2017. [ Google Scholar ]
- Fernández, A.; Garcia, S.; Herrera, F.; Chawla, N.V. SMOTE for learning from imbalanced data: Progress and challenges, marking the 15-year anniversary. J. Artif. Intell. Res. 2018 , 61 , 863–905. [ Google Scholar ] [ CrossRef ]
- Blagus, R.; Lusa, L. SMOTE for high-dimensional class-imbalanced data. BMC Bioinform. 2013 , 14 , 1–16. [ Google Scholar ] [ CrossRef ]
- Deepa, B.; Ramesh, K. Epileptic seizure detection using deep learning through min max scaler normalization. Int. J. Health Sci. 2022 , 6 , 10981–10996. [ Google Scholar ] [ CrossRef ]
- Sembiring, I.; Wahyuni, S.N.; Sediyono, E. LSTM algorithm optimization for COVID-19 prediction model. Heliyon 2024 , 10 , e26158. [ Google Scholar ] [ CrossRef ]
- O’Donncha, F.; Hu, Y.; Palmes, P.; Burke, M.; Filgueira, R.; Grant, J. A spatio-temporal LSTM model to forecast across multiple temporal and spatial scales. Ecol. Inform. 2022 , 69 , 101687. [ Google Scholar ] [ CrossRef ]
- Olhosseiny, H.H.; Mirzaloo, M.; Bolic, M.; Dajani, H.R.; Groza, V.; Yoshida, M. Identifying high risk of atherosclerosis using deep learning and ensemble learning. In Proceedings of the 2021 IEEE International Symposium on Medical Measurements and Applications (MeMeA), Lausanne, Switzerland, 23–25 June 2021. [ Google Scholar ]
- An, Y.; Huang, N.; Chen, X.; Wu, F.; Wang, J. High-risk prediction of cardiovascular diseases via attention-based deep neural networks. IEEE ACM Trans. Comput. Biol. Bioinform. 2019 , 18 , 1093–1105. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Baccouche, A.; Garcia-Zapirain, B.; Olea, C.C.; Elmaghraby, A. Ensemble deep learning models for heart disease classification: A case study from Mexico. Information 2020 , 11 , 207. [ Google Scholar ] [ CrossRef ]
- Bai, S.; Yan, M.; Wan, Q.; He, L.; Wang, X.; Li, J. DL-RNN: An accurate indoor localization method via double RNNs. IEEE Sens. J. 2019 , 20 , 286–295. [ Google Scholar ] [ CrossRef ]
- Dey, R.; Salem, F.M. Gate-variants of gated recurrent unit (GRU) neural networks. In Proceedings of the 2017 IEEE 60th International Midwest Symposium on Circuits and Systems (MWSCAS), Boston, MA, USA, 6–9 August 2017. [ Google Scholar ]
- Wang, J.J.; Yan, J.; Li, C.; Gao, R.X.; Zhao, R. Deep heterogeneous GRU model for predictive analytics in smart manufacturing: Application to tool wear prediction. Comput. Ind. 2019 , 111 , 1–14. [ Google Scholar ] [ CrossRef ]
- Creswell, A.; White, T.; Dumoulin, V.; Arulkumaran, K.; Sengupta, B.; Bharath, A.A. Generative adversarial networks: An overview. IEEE Signal Process. Mag. 2018 , 35 , 53–65. [ Google Scholar ] [ CrossRef ]
- Dhyani, M.; Kumar, R. An intelligent Chatbot using deep learning with Bidirectional RNN and attention model. Mater. Today Proc. 2021 , 34 , 817–824. [ Google Scholar ] [ CrossRef ]
- Cui, Z.; Ke, R.; Pu, Z.; Wang, Y. Stacked bidirectional and unidirectional LSTM recurrent neural network for forecasting network-wide traffic state with missing values. Transp. Res. Part C Emerg. Technol. 2020 , 118 , 102674. [ Google Scholar ] [ CrossRef ]
- Chen, D.; Yongchareon, S.; Lai, E.M.-K.; Yu, J.; Sheng, Q.Z.; Li, Y. Transformer with bidirectional GRU for nonintrusive, sensor-based activity recognition in a multiresident environment. IEEE Internet Things J. 2022 , 9 , 23716–23727. [ Google Scholar ] [ CrossRef ]
- Mostafa, A.L.; Abdel-Galil, H.; Belal, M. Ensemble Model-based Weighted Categorical Cross-entropy Loss for Facial Expression Recognition. In Proceedings of the 2021 Tenth International Conference on Intelligent Computing and Information Systems (ICICIS), Cairo, Egypt, 5–6 December 2021. [ Google Scholar ]
- Feng, L.; Shu, S.; Lin, Z.; Lv, F.; Li, L.; An, B. Can cross entropy loss be robust to label noise? In Proceedings of the Twenty-Ninth International Conference on International Joint Conferences on Artificial Intelligence, Online, 7–15 January 2021.
- Ruby, U.; Yendapalli, V. Binary cross entropy with deep learning technique for image classification. Int. J. Adv. Trends Comput. Sci. Eng. 2020 , 9 , 5393–5397. [ Google Scholar ]
- Hernández-Vázquez, M.A.; Hernández-Rodríguez, Y.M.; Cortes-Rojas, F.D.; Bayareh-Mancilla, R.; Cigarroa-Mayorga, O.E. Hybrid Feature Mammogram Analysis: Detecting and Localizing Microcalcifications Combining Gabor, Prewitt, GLCM Features, and Top Hat Filtering Enhanced with CNN Architecture. Diagnostics 2024 , 14 , 1691. [ Google Scholar ] [ CrossRef ]
- Suri, J.S.; Agarwal, S.; Carriero, A.; Paschè, A.; Danna, P.S.; Columbu, M.; Saba, L.; Viskovic, K.; Mehmedović, A.; Agarwal, S. COVLIAS 1.0 vs. MedSeg: Artificial intelligence-based comparative study for automated COVID-19 computed tomography lung segmentation in Italian and Croatian Cohorts. Diagnostics 2021 , 11 , 2367. [ Google Scholar ] [ CrossRef ]
- Daneshjou, R.; Smith, M.P.; Sun, M.D.; Rotemberg, V.; Zou, J. Lack of transparency and potential bias in artificial intelligence data sets and algorithms: A scoping review. JAMA Dermatol. 2021 , 157 , 1362–1369. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Dubey, A.K.; Chabert, G.L.; Carriero, A.; Pasche, A.; Danna, P.S.; Agarwal, S.; Mohanty, L.; Nillmani; Sharma, N.; Yadav, S. Ensemble Deep Learning Derived from Transfer Learning for Classification of COVID-19 Patients on Hybrid Deep-Learning-Based Lung Segmentation: A Data Augmentation and Balancing Framework. Diagnostics 2023 , 13 , 1954. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Saba, L.; Than, J.C.; Noor, N.M.; Rijal, O.M.; Kassim, R.M.; Yunus, A.; Ng, C.R.; Suri, J.S. Inter-observer variability analysis of automatic lung delineation in normal and disease patients. J. Med. Syst. 2016 , 40 , 1–18. [ Google Scholar ] [ CrossRef ]
- Suri, J.S.; Agarwal, S.; Saba, L.; Chabert, G.L.; Carriero, A.; Paschè, A.; Danna, P.; Mehmedović, A.; Faa, G.; Jujaray, T. Multicenter study on COVID-19 lung computed tomography segmentation with varying glass ground opacities using unseen deep learning artificial intelligence paradigms: COVLIAS 1.0 validation. J. Med. Syst. 2022 , 46 , 62. [ Google Scholar ] [ CrossRef ]
- Unnikrishnan, P.; Kumar, D.K.; Arjunan, S.P.; Kumar, H.; Mitchell, P.; Kawasaki, R. Development of health parameter model for risk prediction of CVD using SVM. Comput. Math. Methods Med. 2016 , 2016 , 3016245. [ Google Scholar ] [ CrossRef ]
- Zhou, R.; Guo, F.; Azarpazhooh, M.R.; Hashemi, S.; Cheng, X.; Spence, J.D.; Ding, M.; Fenster, A. Deep learning-based measurement of total plaque area in B-mode ultrasound images. IEEE J. Biomed. Health Inform. 2021 , 25 , 2967–2977. [ Google Scholar ] [ CrossRef ]
- Jain, P.K.; Sharma, N.; Giannopoulos, A.A.; Saba, L.; Nicolaides, A.; Suri, J.S. Hybrid deep learning segmentation models for atherosclerotic plaque in internal carotid artery B-mode ultrasound. Comput. Biol. Med. 2021 , 136 , 104721. [ Google Scholar ] [ CrossRef ]
- Jain, P.K.; Sharma, N.; Saba, L.; Paraskevas, K.I.; Kalra, M.K.; Johri, A.; Laird, J.R.; Nicolaides, A.N.; Suri, J.S. Unseen artificial intelligence—Deep learning paradigm for segmentation of low atherosclerotic plaque in carotid ultrasound: A multicenter cardiovascular study. Diagnostics 2021 , 11 , 2257. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Jain, P.K.; Sharma, N.; Saba, L.; Paraskevas, K.I.; Kalra, M.K.; Johri, A.; Nicolaides, A.N.; Suri, J.S. Automated deep learning-based paradigm for high-risk plaque detection in B-mode common carotid ultrasound scans: An asymptomatic Japanese cohort study. Int. Angiol. 2021 , 41 , 9–23. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Agarwal, M.; Agarwal, S.; Saba, L.; Chabert, G.L.; Gupta, S.; Carriero, A.; Pasche, A.; Danna, P.; Mehmedovic, A.; Faa, G. Eight pruning deep learning models for low storage and high-speed COVID-19 computed tomography lung segmentation and heatmap-based lesion localization: A multicenter study using COVLIAS 2.0. Comput. Biol. Med. 2022 , 146 , 105571. [ Google Scholar ] [ CrossRef ]
- Suri, J.S.; Bhagawati, M.; Paul, S.; Protogeron, A.; Sfikakis, P.P.; Kitas, G.D.; Khanna, N.N.; Ruzsa, Z.; Sharma, A.M.; Saxena, S. Understanding the bias in machine learning systems for cardiovascular disease risk assessment: The first of its kind review. Comput. Biol. Med. 2022 , 142 , 105204. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Narayanan, R.; Werahera, P.; Barqawi, A.; Crawford, E.; Shinohara, K.; Simoneau, A.; Suri, J. Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy. Phys. Med. Biol. 2008 , 53 , N397. [ Google Scholar ] [ CrossRef ]
- Lin, T.-Y.; Goyal, P.; Girshick, R.; He, K.; Dollár, P. Focal loss for dense object detection. In Proceedings of the IEEE International Conference on Computer Vision, Venice, Italy, 22–29 October 2017. [ Google Scholar ]
- Bartlett, P.L.; Wegkamp, M.H. Classification with a Reject Option using a Hinge Loss. J. Mach. Learn. Res. 2008 , 9 , 1823–1840. [ Google Scholar ]
- Bénédict, G.; Koops, V.; Odijk, D.; de Rijke, M. SigmoidF1: A smooth F1 score surrogate loss for multilabel classification. arXiv 2021 , arXiv:2108.10566. [ Google Scholar ]
- Kyriacou, E.C.; Petroudi, S.; Pattichis, C.S.; Pattichis, M.S.; Griffin, M.; Kakkos, S.; Nicolaides, A. Prediction of high-risk asymptomatic carotid plaques based on ultrasonic image features. IEEE Trans. Inf. Technol. Biomed. 2012 , 16 , 966–973. [ Google Scholar ] [ CrossRef ]
- El-Barghouty, N.; Nicolaides, A.; Bahal, V.; Geroulakos, G.; Androulakis, A. The identification of the high risk carotid plaque. Eur. J. Vasc. Endovasc. Surg. 1996 , 11 , 470–478. [ Google Scholar ] [ CrossRef ]
- Stoitsis, J.; Golemati, S.; Nikita, K.; Nicolaides, A. Characterization of carotid atherosclerosis based on motion and texture features and clustering using fuzzy c-means. In Proceedings of the 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, San Francisco, CA, USA, 1–5 September 2004. [ Google Scholar ]
- Loizou, C.P.; Petroudi, S.; Pantziaris, M.; Nicolaides, A.N.; Pattichis, C.S. An integrated system for the segmentation of atherosclerotic carotid plaque ultrasound video. IEEE Trans. Ultrason. Ferroelectr. Freq. Control. 2014 , 61 , 86–101. [ Google Scholar ] [ CrossRef ]
- Stoitsis, J.; Golemati, S.; Kendros, S.; Nikita, K. Automated detection of the carotid artery wall in B-mode ultrasound images using active contours initialized by the Hough transform. In Proceedings of the 2008 30th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Vancouver, BC, Canada, 20–25 August 2008. [ Google Scholar ]
- Matsakou, A.I.; Golemati, S.; Stoitsis, J.S.; Nikita, K.S. Automated detection of the carotid artery wall in longitudinal B-mode images using active contours initialized by the Hough transform. In Proceedings of the 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society, Boston, MA, USA, 30 August–2 September 2011. [ Google Scholar ]
- Suri, J.S. Two-dimensional fast magnetic resonance brain segmentation. IEEE Eng. Med. Biol. Mag. 2001 , 20 , 84–95. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Kiernan, M.J.; Al Mukaddim, R.; Mitchell, C.C.; Maybock, J.; Wilbrand, S.M.; Dempsey, R.J.; Varghese, T. Lumen segmentation using a Mask R-CNN in carotid arteries with stenotic atherosclerotic plaque. Ultrasonics 2024 , 137 , 107193. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Zhou, R.; Guo, F.; Azarpazhooh, M.R.; Spence, J.D.; Gan, H.; Ding, M.; Fenster, A. Carotid vessel-wall-volume ultrasound measurement via a UNet++ ensemble algorithm trained on small data sets. Ultrasound Med. Biol. 2023 , 49 , 1031–1036. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- El-Baz, A.; Suri, J.S. Big Data in Multimodal Medical Imaging ; CRC Press: Boca Raton, FL, USA, 2019. [ Google Scholar ]
- Rumsfeld, J.S.; Joynt, K.E.; Maddox, T.M. Big data analytics to improve cardiovascular care: Promise and challenges. Nat. Rev. Cardiol. 2016 , 13 , 350–359. [ Google Scholar ] [ CrossRef ]
- Krittanawong, C.; Johnson, K.W.; Hershman, S.G.; Tang, W.W. Big data, artificial intelligence, and cardiovascular precision medicine. Expert Rev. Precis. Med. Drug Dev. 2018 , 3 , 305–317. [ Google Scholar ] [ CrossRef ]
- Hulsen, T.; Friedecký, D.; Renz, H.; Melis, E.; Vermeersch, P.; Fernandez-Calle, P. From big data to better patient outcomes. Clin. Chem. Lab. Med. CCLM 2023 , 61 , 580–586. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Dabla, P.K. Unlocking new potential of clinical diagnosis with artificial intelligence: Finding new patterns of clinical and lab data. World J. Diabetes 2024 , 15 , 308. [ Google Scholar ] [ CrossRef ]
- Wang, S.; Xie, T.; Liu, H.; Zhang, X.; Cheng, J. PSE-Net: Channel pruning for Convolutional Neural Networks with parallel-subnets estimator. Neural Netw. 2024 , 174 , 106263. [ Google Scholar ] [ CrossRef ]
- Louati, H.; Louati, A.; Bechikh, S.; Kariri, E. Embedding channel pruning within the CNN architecture design using a bi-level evolutionary approach. J. Supercomput. 2023 , 79 , 16118–16151. [ Google Scholar ] [ CrossRef ]
- Hong, W.; Li, G.; Liu, S.; Yang, P.; Tang, K. Multi-objective evolutionary optimization for hardware-aware neural network pruning. Fundam. Res. 2022 , 4 , 941–950. [ Google Scholar ] [ CrossRef ] [ PubMed ]
- Hollmann, N.; Müller, S.; Eggensperger, K.; Hutter, F. Tabpfn: A transformer that solves small tabular classification problems in a second. arXiv 2022 , arXiv:2207.01848. [ Google Scholar ]
- Huang, X.; Khetan, A.; Cvitkovic, M.; Karnin, Z. Tabtransformer: Tabular data modeling using contextual embeddings. arXiv 2020 , arXiv:2012.06678. [ Google Scholar ]
- Somepalli, G.; Goldblum, M.; Schwarzschild, A.; Bruss, C.B.; Goldstein, T. Saint: Improved neural networks for tabular data via row attention and contrastive pre-training. arXiv 2021 , arXiv:2106.01342. [ Google Scholar ]
- Makris, G.C.; Lavida, A.; Griffin, M.; Geroulakos, G.; Nicolaides, A.N. Three-dimensional ultrasound imaging for the evaluation of carotid atherosclerosis. Atherosclerosis 2011 , 219 , 377–383. [ Google Scholar ] [ CrossRef ]
- Kyriacou, E.C.; Pattichis, C.; Pattichis, M.; Loizou, C.; Christodoulou, C.; Kakkos, S.K.; Nicolaides, A. A review of noninvasive ultrasound image processing methods in the analysis of carotid plaque morphology for the assessment of stroke risk. IEEE Trans. Inf. Technol. Biomed. 2010 , 14 , 1027–1038. [ Google Scholar ] [ CrossRef ]
- Chen, Z.; Jiang, M.; Chiu, B. Unsupervised shape-and-texture-based generative adversarial tuning of pre-trained networks for carotid segmentation from 3D ultrasound images. Med. Phys. 2024 . early view . [ Google Scholar ] [ CrossRef ]
CVP | Models | ACC (%) | SPEC (%) | SEN (%) | p-Value | AUC (0–1) |
---|
K2 | RNN | 80.11 | 82.96 | 81.87 | <0.001 | 0.883 |
GRU | 81.12 | 83.32 | 82.16 | <0.001 | 0.892 |
LSTM | 81.81 | 85.67 | 83.36 | <0.001 | 0.907 |
K4 | RNN | 82.52 | 81.97 | 83.88 | <0.001 | 0.850 |
GRU | 83.13 | 82.33 | 84.17 | <0.001 | 0.897 |
LSTM | 84.82 | 84.68 | 85.37 | <0.001 | 0.908 |
K5 | RNN | 83.50 | 82.95 | 84.86 | <0.001 | 0.895 |
GRU | 84.11 | 83.31 | 85.15 | <0.001 | 0.900 |
LSTM | 85.80 | 85.66 | 86.35 | <0.001 | 0.916 |
K10 | RNN | 84.20 | 83.15 | 83.86 | <0.001 | 0.896 |
GRU | 85.12 | 84.11 | 86.15 | <0.001 | 0.902 |
LSTM | 86.80 | 86.67 | 87.35 | <0.001 | 0.918 |
CVP. | Models | ACC (%) | SPEC (%) | SEN (%) | p-Value | AUC (0–1) |
---|
K2 | BiRNN | 82.22 | 80.16 | 82.34 | <0.001 | 0.891 |
BiGRU | 83.42 | 81.17 | 83.18 | <0.001 | 0.905 |
BiLSTM | 84.32 | 83.29 | 84.12 | <0.001 | 0.913 |
K4 | BiRNN | 83.28 | 82.66 | 83.94 | <0.001 | 0.910 |
BiGRU | 84.24 | 83.12 | 84.28 | <0.001 | 0.915 |
BiLSTM | 85.13 | 85.68 | 86.52 | <0.001 | 0.923 |
K5 | BiRNN | 84.28 | 83.66 | 84.94 | <0.001 | 0.920 |
BiGRU | 85.24 | 84.12 | 85.28 | <0.001 | 0.925 |
BiLSTM | 86.13 | 86.68 | 87.52 | <0.001 | 0.933 |
K10 | BiRNN | 85.27 | 84.65 | 85.93 | <0.001 | 0.920 |
BiGRU | 86.23 | 85.11 | 86.27 | <0.001 | 0.925 |
BiLSTM | 87.00 | 86.67 | 88.51 | <0.001 | 0.935 |
CVP | Models | ACC (%) | SPEC (%) | SEN (%) | p-Value | AUC (0–1) |
---|
K2 | RNN + GRU | 85.00 | 82.76 | 82.62 | <0.001 | 0.930 |
RNN + LSTM | 85.91 | 85.37 | 83.56 | <0.001 | 0.939 |
LSTM + GRU | 88.02 | 88.16 | 84.62 | <0.001 | 0.943 |
BiRNN + BiGRU | 90.53 | 89.75 | 88.32 | <0.001 | 0.954 |
BiRNN + BiLSTM | 91.84 | 90.18 | 88.32 | <0.001 | 0.968 |
BiLSTM + BiGRU | 94.14 | 92.22 | 89.12 | <0.001 | 0.974 |
K4 | RNN + GRU | 86.66 | 83.76 | 83.62 | <0.001 | 0.931 |
RNN + LSTM | 86.02 | 86.37 | 84.56 | <0.001 | 0.940 |
LSTM + GRU | 89.02 | 89.16 | 85.62 | <0.001 | 0.944 |
BiRNN + BiGRU | 91.53 | 90.75 | 87.32 | <0.001 | 0.955 |
BiRNN + BiLSTM | 92.84 | 91.18 | 89.32 | <0.001 | 0.969 |
BiLSTM + BiGRU | 95.14 | 93.22 | 90.12 | <0.001 | 0.975 |
K5 | RNN + GRU | 86.45 | 82.76 | 84.62 | <0.001 | 0.947 |
RNN + LSTM | 86.50 | 85.37 | 86.56 | <0.001 | 0.957 |
LSTM + GRU | 91.02 | 88.16 | 87.62 | <0.001 | 0.959 |
BiRNN + BiGRU | 93.53 | 84.75 | 87.32 | <0.001 | 0.972 |
BiRNN + BiLSTM | 94.84 | 86.18 | 87.32 | <0.001 | 0.976 |
BiLSTM + BiGRU | 96.14 | 92.22 | 93.12 | <0.001 | 0.982 |
K10 | RNN + GRU | 88.14 | 82.75 | 84.61 | <0.001 | 0.948 |
RNN + LSTM | 88.24 | 84.36 | 85.55 | <0.001 | 0.958 |
LSTM + GRU | 92.01 | 87.15 | 86.61 | <0.001 | 0.960 |
BiRNN + BiGRU | 94.52 | 88.74 | 87.31 | <0.001 | 0.975 |
BiRNN + BiLSTM | 95.83 | 89.17 | 87.31 | <0.001 | 0.979 |
BiLSTM + BiGRU | 97.25 | 92.21 | 93.11 | <0.001 | 0.985 |
SN | PCA | CST | RFR |
---|
1 | Age | Age | Age |
2 | Diabetes T1D | Diabetes T1D | Diabetes T1 D |
3 | Avg Sys before angio | Avg Sys before angio | Avg Sys before angio |
4 | IPN | IPN | IPN |
5 | Creatinine | Creatinine | Creatinine |
6 | Hyperlipidemia | Hyperlipidemia | Hyperlipidemia |
7 | Alpha-Blockers | Alpha-Blockers | Alpha-Blockers |
8 | Insulin | Family Hx of CVD | Current Smoker |
9 | Angina | Current Smoker | BMI |
10 | Anti-Platelet/Anti-Coagulants | Anti-Platelet/Anti-Coagulants | TPA |
SN | M1 (a) | M2 (b) | % Increase (a − b/a) × 100 |
---|
1 | ML | HDL | 30.20% |
2 | UniDL | HDL | 8.72% |
3 | BiDL | HDL | 7.26% |
Seen Data | Unseen Data |
---|
SN | Models | Mean AUC (0–1) | p-Value | Mean AUC (0–1) | p-Value | Difference (%) |
---|
1 | ML | 0.702 | <0.005 | 0.683 | <0.005 | 2.78% |
2 | UniDL | 0.910 | <0.001 | 0.884 | <0.001 | 2.94% |
3 | BiDL | 0.931 | <0.001 | 0.905 | <0.001 | 2.87% |
4 | HDL | 0.956 | <0.001 | 0.939 | <0.001 | 1.79% |
SN | Model1 | Model2 | Mann-Whitney |
---|
1 | BiRNN | RNN | p < 0.05 |
2 | BiGRU + BiRNN | RNN | p < 0.05 |
3 | BiRNN + BiLSTM | BiRNN | p < 0.05 |
4 | BiRNN + BiLSTM | RNN | p < 0.05 |
5 | BiRNN + BiGRU | BiRNN | p < 0.05 |
6 | BiRNN + BiGRU | RNN | p < 0.05 |
7 | BiLSTM + BiGRU | RNN | p < 0.05 |
8 | BiLSTM + BiGRU | BiRNN | p < 0.05 |
C0 | C1 | C2 | C3 | C4 | C5 | C6 | C7 |
---|
SN | Authors | NOF | ML/DL Models Used | #Patients/#Images | CV | SV | Results Obtained |
R1 | Unnikrishnan et al. [ ] | 09 | SVM | 2.4 K | K5 | 🗴 | AUC for ML = 0.71; for CCVRC = 0.57 |
R2 | Jamthikar et al. [ ] | 39 | RF, SVM, XGBoost | 500 | K10 | ✓ | AUC for ML = 0.95; for CCVRC = 0.50 |
R3 | Alaa et al. [ ] | 473 | SVM, GBM, RF, AdaBoost | 423.6 K | K10 | 🗴 | AUC for ML = 0.724; for CCVRC = 0.774 |
R4 | Zhou et al. [ ] | 🗴 | UNet++ | 144/510 497/638 | K5 | 🗴 | TPA error = 5.55 ± 4.34 mm ; DSC = 83.3–85.7% |
R5 | Jain et al. [ ] | 🗴 | UNet+, UNet, SegNetUNet, SegNet, Unet + SegNet | 97/970 | K5 | 🗴 | AUC for UNet = 0.91, for UNet + = 0.91, for SegNet-UNet = 0.908, for SegNet = 0.905, and for SegNetUNet+ = 0.898 (using CE-loss models) and 0.883, 0.889, 0.905, 0.889, and 0.907 (using DSC-loss models); PA error = 3.49 mm for SDL and 4.21 mm for HDL |
R6 | Jain et al. [ ] | 24 | UNet | 379, 300 | K10 | 🗴 | Unseen FoM: 70.96 and 91.14 Seen FoM: 97.57, 88.89, and 99.14 |
R7 | Jain et al. [ ] | 24 | 🗴 AtheroEdge 2.0, UNet, UNetSegNet | 379 | K10 | 🗴 | AUC for UNet = 0.93, for SegNet-UNet = 0.94; for AtheroEdge™ 2.0 = 0.95, respectively; SDL PA error = 9.9 mm ; HDL PA error = 8 mm ; AtheroEdge™ = 2.0 mm ; PA error = 9.6 mm |
R8 | Johri et al. [ ] | 39 | RF, SVM, RNN, LSTM | 500 | K10 | ✓ | AUC for DL AUC = 0.99, for ML = 0.89, for CCVRC = 0.50 |
R9 | Akari et al. [ ] | 56 | SVM | 4004 | K10 | ✓ | ACC = 98.43; reliability index = 97.32% |
R10 | Proposed method | 39 | SVM, RF, XGBoost, UniDL, BiDL, HDL | 500 | K2, K4, K5, K10 | ✓ | AUC for ML = 0.702, for UniDL = 0.910, for BiDL = 0.931, and for HDL = 0.956 |
| The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
Share and Cite
Bhagawati, M.; Paul, S.; Mantella, L.; Johri, A.M.; Gupta, S.; Laird, J.R.; Singh, I.M.; Khanna, N.N.; Al-Maini, M.; Isenovic, E.R.; et al. Cardiovascular Disease Risk Stratification Using Hybrid Deep Learning Paradigm: First of Its Kind on Canadian Trial Data. Diagnostics 2024 , 14 , 1894. https://doi.org/10.3390/diagnostics14171894
Bhagawati M, Paul S, Mantella L, Johri AM, Gupta S, Laird JR, Singh IM, Khanna NN, Al-Maini M, Isenovic ER, et al. Cardiovascular Disease Risk Stratification Using Hybrid Deep Learning Paradigm: First of Its Kind on Canadian Trial Data. Diagnostics . 2024; 14(17):1894. https://doi.org/10.3390/diagnostics14171894
Bhagawati, Mrinalini, Sudip Paul, Laura Mantella, Amer M. Johri, Siddharth Gupta, John R. Laird, Inder M. Singh, Narendra N. Khanna, Mustafa Al-Maini, Esma R. Isenovic, and et al. 2024. "Cardiovascular Disease Risk Stratification Using Hybrid Deep Learning Paradigm: First of Its Kind on Canadian Trial Data" Diagnostics 14, no. 17: 1894. https://doi.org/10.3390/diagnostics14171894
Article Metrics
Article access statistics, further information, mdpi initiatives, follow mdpi.
![MDPI Open Access Journals MDPI](https://pub.mdpi-res.com/img/design/mdpi-pub-logo-white-small.png?71d18e5f805839ab?1724941758)
Subscribe to receive issue release notifications and newsletters from MDPI journals
![](//mangareview.fun/777/templates/cheerup/res/banner1.gif)
IMAGES
VIDEO
COMMENTS
P Value Definition. A p value is used in hypothesis testing to help you support or reject the null hypothesis. The p value is the evidence against a null hypothesis. The smaller the p-value, the stronger the evidence that you should reject the null hypothesis. P values are expressed as decimals although it may be easier to understand what they ...
Medical providers often rely on evidence-based medicine to guide decision-making in practice. Often a research hypothesis is tested with results provided, typically with p values, confidence intervals, or both. Additionally, statistical or research significance is estimated or determined by the investigators. Unfortunately, healthcare providers may have different comfort levels in interpreting ...
To find the p value for your sample, do the following: Identify the correct test statistic. Calculate the test statistic using the relevant properties of your sample. Specify the characteristics of the test statistic's sampling distribution. Place your test statistic in the sampling distribution to find the p value.
It can be shown using statistical software that the P-value is 0.0127. The graph depicts this visually. The P-value, 0.0127, tells us it is "unlikely" that we would observe such an extreme test statistic t* in the direction of H A if the null hypothesis were true. Therefore, our initial assumption that the null hypothesis is true must be incorrect.
A p-value, or probability value, is a number describing how likely it is that your data would have occurred by random chance (i.e., that the null hypothesis is true). The level of statistical significance is often expressed as a p-value between 0 and 1. The smaller the p -value, the less likely the results occurred by random chance, and the ...
Here is the technical definition of P values: P values are the probability of observing a sample statistic that is at least as extreme as your sample statistic when you assume that the null hypothesis is true. Let's go back to our hypothetical medication study. Suppose the hypothesis test generates a P value of 0.03.
The p -value is used in the context of null hypothesis testing in order to quantify the statistical significance of a result, the result being the observed value of the chosen statistic . [note 2] The lower the p -value is, the lower the probability of getting that result if the null hypothesis were true. A result is said to be statistically ...
To determine the p-value, you need to know the distribution of your test statistic under the assumption that the null hypothesis is true.Then, with the help of the cumulative distribution function (cdf) of this distribution, we can express the probability of the test statistics being at least as extreme as its value x for the sample:Left-tailed test:
Hypothesis testing is a vital process in inferential statistics where the goal is to use sample data to draw conclusions about an entire population. In the testing process, you use significance levels and p-values to determine whether the test results are statistically significant.
The results of hypothesis testing will be presented in the results and discussion sections of your research paper, dissertation or thesis. In the results section you should give a brief summary of the data and a summary of the results of your statistical test (for example, the estimated difference between group means and associated p-value).
The p-value, or probability value, is a statistical measure used in hypothesis testing to assess the strength of evidence against a null hypothesis. It represents the probability of obtaining results as extreme as, or more extreme than, the observed results under the assumption that the null hypothesis is true.
It is the cutoff probability for p-value to establish statistical significance for a given hypothesis test. For an observed effect to be considered as statistically significant, the p-value of the test should be lower than the pre-decided alpha value. Typically for most statistical tests (but not always), alpha is set as 0.05.
P-value is the level of marginal significance within a statistical hypothesis test, representing the probability of the occurrence of a given event.
A statistical hypothesis test has a null hypothesis, the status quo, what we assume to be true. Notation is H 0, read as "H naught". ... The p-value can also be thought of as the probability that the results (from the sample) that we are seeing are solely due to chance. This concept will be discussed in much further detail in the class notes.
Khanmigo is now free for all US educators! Plan lessons, develop exit tickets, and so much more with our AI teaching assistant.
When a P value is less than or equal to the significance level, you reject the null hypothesis. If we take the P value for our example and compare it to the common significance levels, it matches the previous graphical results. The P value of 0.03112 is statistically significant at an alpha level of 0.05, but not at the 0.01 level.
Note: The p-value is the probability of obtaining a test statistic as extreme as, or more extreme than, the one observed in the sample, assuming the null hypothesis is true. To determine p-value for hypothesis testing, we typically refer to a statistical distribution table , such as the normal distribution or t-distribution tables based on.
The p-value or probability value is a number, calculated from a statistical test, that tells how likely it is that your results would have occurred under the null hypothesis of the test. P-values are usually automatically calculated using statistical software. They can also be calculated using p-value tables for the relevant statistical test.
The P-value is known as the level of marginal significance within the hypothesis testing that represents the probability of occurrence of the given event. The P-value is used as an alternative to the rejection point to provide the least significance at which the null hypothesis would be rejected. If the P-value is small, then there is stronger ...
A P-value calculator is used to determine the statistical significance of an observed result in hypothesis testing. It takes as input the observed test statistic, the null hypothesis, and the relevant parameters of the statistical test (such as degrees of freedom), and computes the p-value. The p-value represents the probability of obtaining ...
The p-value is the probability of observing test results at least as extreme as the results observed, assuming the null hypothesis is correct. It helps determine the strength of the evidence against the null hypothesis.
1.4 p-Values and Formal Statistical Tests Jason Banfelder September 21st, 2023 1 Introduction to p-values We have already seen one example of formal statistical testing when we tested for the normality of a sample from a univariate distribution. To reiterate, formal statistical testing begins with a statement of the null hypothesis, H 0. The ...
Statistics document from University of Mississippi, 2 pages, Question 1 A. Hypotheses: H0:μ=60 Ha:μ≠60 Test statistic = (58.5-60)/(6/7) = -1.75 P-Value P(Z≤−1.75)≈0.0401 Two-tailed P-value=2×0.0401=0.0802 Since P=0.0802>0.05, we fail to reject H 0. There is not enough evidence to conclude the true mean is different
Advantages of Bayesian Statistics. It handles multiple tests well. Since testing isn't forced into a true/false proposition, Bayesian statistics is well-suited for multiple testing situations. It offers incorporation of previous information and continuous updating. Bayesian statistics shines in situations where there's a lot of prior data.
The AtheroEdge™ 3.0 HDL was scientifically validated using seen and unseen datasets while the reliability and statistical tests were conducted using CST along with p-value significance. The performance of AtheroEdge™ 3.0 HDL was evaluated by measuring the p-value and area-under-the-curve for both seen and unseen data.